You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
2 March 2021
Cardiol Therapeutics stellt Antrag auf Nasdaq-Uplisting und erzielt Erlöse von mehr als 10 Mio. USD aus der Ausübung von Optionsscheinen und Optionen
25 November 2019
Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency
27 February 2024
Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
19 January 2024
30 August 2023
24 May 2023
11 April 2023
14 May 2022
Original-Research: Cardiol Therapeutics Inc. (von GBC AG): International Investment Forum
